Skip to main content
PZ Cormay S.A. logo

PZ Cormay S.A. — Investor Relations & Filings

Ticker · CRM ISIN · PLCMRAY00029 LEI · 2594006HZJ8OSNK56U87 WAR Manufacturing
Open in API
Filings indexed 692 across all filing types
Latest filing 2016-05-16 Audit Report / Informat…
Country PL Poland
Listing WAR CRM

About PZ Cormay S.A.

https://cormaydiagnostics.com/

PZ Cormay S.A. is a manufacturer and distributor of in-vitro diagnostic (IVD) solutions for medical laboratories and clinics. The company develops, produces, and sells a comprehensive portfolio of diagnostic reagents, laboratory analyzers, and quality control systems. Its offerings cater to key diagnostic areas, including clinical chemistry, hematology, and immunoassay. Key product lines feature the Accent series of chemistry analyzers, the Auryx immunoassay system, and the Mythic family of hematology analyzers. The company integrates its extensive experience in reagent manufacturing with advanced Swiss hematology technology to provide reliable, high-performance, and cost-effective diagnostic tools to a global network of distributors and healthcare professionals.

Recent filings

Filing Released Lang Actions
RB_14_2016_zalacznik.pdf
Audit Report / Information Classification · 95% confidence The document is titled "Zestawienie korekt do Skonsolidowanego raportu rocznego Grupy Kapitałowej PZ CORMAY za rok 2015" (Statement of corrections to the Consolidated Annual Report of the PZ CORMAY Capital Group for the year 2015). It explicitly details numerous corrections ('Było' vs 'Jest') across various sections of the financial statements, including Selected Financial Data, Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Earnings Per Share notes, all pertaining to the 2015 annual figures. This document is a formal correction/restatement related to a previously published Annual Report (which would typically be a 10-K equivalent in a US context, or a full annual report filing). Since it is a detailed correction document attached to a current report ('Załącznik do Raportu bieżącego nr 14/2016'), and it directly amends the content of the full annual financial statements, it is best classified as part of the Audit Report/Information (AR) category, as it deals with the integrity and final figures of the audited annual statements, or potentially as a Regulatory Filing (RNS) if it were just an announcement. However, given the extensive detail of the financial restatements, it functions as a critical component of the annual audit/financial reporting process being corrected. Since '10-K' is reserved for the full annual report itself, and this is an amendment/correction document, 'AR' (Audit Report / Information) is the most appropriate fit among the provided options for detailed financial statement adjustments. FY 2015
2016-05-16 Polish
Załącznik do raportu
Audit Report / Information Classification · 95% confidence The document is titled "Zestawienie korekt do Skonsolidowanego raportu rocznego Grupy Kapitałowej PZ CORMAY za rok 2015" (Statement of corrections to the Consolidated Annual Report of the PZ CORMAY Capital Group for the year 2015). It explicitly details numerous corrections ('Było' vs 'Jest') across various sections of the financial statements, including Selected Financial Data, Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Earnings Per Share notes, all pertaining to the 2015 annual figures. This document is a formal correction/restatement related to a previously published Annual Report (which would typically be a 10-K equivalent in a US context, or a full annual report filing). Since it is a detailed correction document attached to a current report ('Załącznik do Raportu bieżącego nr 14/2016'), and it directly amends the content of the full annual financial statements, it is best classified as part of the Audit Report/Information (AR) category, as it deals with the integrity and final figures of the audited annual statements, or potentially as a Regulatory Filing (RNS) if it were just an announcement. However, given the extensive detail of the financial restatements, it functions as a critical component of the annual audit/financial reporting process being corrected. Since '10-K' is reserved for the full annual report itself, and this is an amendment/correction document, 'AR' (Audit Report / Information) is the most appropriate fit among the provided options for detailed financial statement adjustments. FY 2015
2016-05-16 Polish
Korekta Skonsolidowanego raportu rocznego GK PZ CORMAY S.A. za rok 2015 - Content (PL)
Audit Report / Information Classification · 95% confidence The document is a formal announcement by the Management Board of PZ CORMAY S.A. regarding a correction ('korekta') to the Consolidated Annual Report ('Skonsolidowanego raportu rocznego') published previously for the year 2015. It details specific pages and sections being corrected (financial statements, notes, etc.). Since this is an announcement *about* a correction to a previously issued report, and not the full report itself, it fits best under the category for general regulatory announcements or filings that don't have a more specific code. Given the nature of correcting a major periodic report, it is a significant regulatory disclosure. While 'AR' (Audit Report/Information) might seem close, this is specifically a correction notice. 'RPA' (Report Publication Announcement) is for announcing the *initial* publication. Therefore, the most appropriate general category for a specific regulatory correction notice that isn't a standard form like 10-K or IR is 'RNS' (Regulatory Filings) as a fallback for miscellaneous regulatory announcements. FY 2015
2016-05-16 Polish
Rekomendacja Narodowego Centrum Badań i Rozwoju do dofinansowania projektu złożonego przez PZ CORMAY S.A. - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1159 characters) from the Management Board of PZ CORMAY S.A. informing the public that the National Centre for Research and Development (NCBR) published a list of projects recommended for co-financing under a specific grant competition. The announcement details the project name, its subject (R&D on diagnostic analyzers), total cost, and the amount of funding recommended. Since this is a notification about an external regulatory/funding body's decision regarding a grant, and it is not a comprehensive financial report (like 10-K or IR), nor a standard capital raise (CAP), it best fits the general 'Regulatory Filings' category as a specific regulatory/grant update that doesn't match other codes. Given the content relates to R&D funding approval, it is a specific regulatory event announcement, making RNS the most appropriate fallback.
2016-05-13 Polish
Zawarcie aneksu do umowy kredytowej - Content (PL)
Capital/Financing Update Classification · 98% confidence The document is a formal announcement by the Management Board (Zarząd) of PZ CORMAY S.A. detailing the amendment (aneks) to an existing credit agreement (umowy o kredyt) with a bank. It specifies the new credit limit (3,000,000 PLN), repayment date, interest terms, and collateral (hipoteka, zastaw rejestrowy, etc.). This content directly relates to the company's financing activities and capital structure changes, specifically securing a line of credit. This aligns perfectly with the definition for Capital/Financing Update (CAP). The legal basis cited is a regulation concerning current and periodic information disclosure, confirming it is a required regulatory filing about a financial event.
2016-04-29 Polish
Informacja o wyborze projektu do dofinansowania przez Polską Agencję Rozwoju Przedsiębiorczości - Content (PL)
Capital/Financing Update Classification · 95% confidence The document text announces that the Management Board of PZ CORMAY S.A. received information that the Polish Agency for Enterprise Development (PARP) published a list of projects selected for co-financing under the Operational Programme Intelligent Development 2014-2020. The announcement details a specific project selected for funding, including its title, scope (implementation of R&D results, construction of a new production plant), and the total cost and co-financing amount. This is a notification regarding receiving funding or a grant for a specific business/R&D initiative, which falls under financing activities or capital structure changes, but more specifically relates to a grant/subsidy award. Given the provided definitions, 'Capital/Financing Update' (CAP) is the most appropriate category as it covers company fundraising and financing activities, which includes receiving significant government grants for development projects. It is not an earnings release, an annual report, or a standard regulatory filing (RNS), but a specific announcement about securing development capital.
2016-04-25 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.